Immune Regulation of Cancer

被引:369
作者
Disis, Mary L. [1 ]
机构
[1] Univ Washington, Ctr Translat Med Womens Hlth, Tumor Vaccine Grp, Seattle, WA 98109 USA
基金
美国国家卫生研究院;
关键词
TUMOR-INFILTRATING LYMPHOCYTES; COLONY-STIMULATING FACTOR; GROWTH-FACTOR-BETA; CELL LUNG-CANCER; CD4(+) T-CELLS; HEPATOCELLULAR-CARCINOMA; FOLLICULAR LYMPHOMA; MELANOMA PATIENTS; SUPPRESSOR-CELLS; HUMAN-PAPILLOMAVIRUS;
D O I
10.1200/JCO.2009.27.2146
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Innate and adaptive immune system cells play a major role in regulating the growth of cancer. Although it is commonly thought that an immune response localized to the tumor will inhibit cancer growth, it is clear that some types of inflammation induced in a tumor may also lead to cancer proliferation, invasion, and dissemination. Recent evidence suggests, however, that some patients with cancer can mount an antitumor immune response that has the potential to control or eliminate cancer. Indeed, a so-called "immune response" signature has been described in malignancy that is associated with improved outcomes in several tumor types. Moreover, the presence of specific subsets of T cells, which have the capability to penetrate tumor stroma and infiltrate deep into the parenchyma, identifies patients with an improved prognosis. Immune-based therapies have the potential to modulate the tumor microenvironment by eliciting immune system cells that will initiate acute inflammation that leads to tissue destruction. J Clin Oncol 28:4531-4538. (C) 2010 by American Society of Clinical Oncology
引用
收藏
页码:4531 / 4538
页数:8
相关论文
共 76 条
[1]   The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages [J].
Allavena, Paola ;
Sica, Antonio ;
Solinas, Graziella ;
Porta, Chiara ;
Mantovani, Alberto .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2008, 66 (01) :1-9
[2]   Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4 [J].
Attia, P ;
Phan, GQ ;
Maker, AV ;
Robinson, MR ;
Quezado, MM ;
Yang, JC ;
Sherry, RM ;
Topalian, SL ;
Kammula, US ;
Royal, RE ;
Restifo, NP ;
Haworth, LR ;
Levy, C ;
Mavroukakis, SA ;
Nichol, G ;
Yellin, MJ ;
Rosenberg, SA .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) :6043-6053
[3]   Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers [J].
Badoual, C ;
Hans, S ;
Rodriguez, J ;
Peyrard, S ;
Klein, C ;
Agueznay, NE ;
Mosseri, V ;
Laccourreye, O ;
Bruneval, P ;
Fridman, WH ;
Brasnu, DF ;
Tartour, E .
CLINICAL CANCER RESEARCH, 2006, 12 (02) :465-472
[4]   Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse [J].
Bates, Gaynor J. ;
Fox, Stephen B. ;
Han, Cheng ;
Leek, Russell D. ;
Garcia, Jose F. ;
Harris, Adrian L. ;
Banham, Alison H. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (34) :5373-5380
[5]   Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma [J].
Bendandi, M ;
Gocke, CD ;
Kobrin, CB ;
Benko, FA ;
Sternas, LA ;
Pennington, R ;
Watson, TM ;
Reynolds, CW ;
Gause, BL ;
Duffey, PL ;
Jaffe, ES ;
Creekmore, SP ;
Longo, DL ;
Kwak, LW .
NATURE MEDICINE, 1999, 5 (10) :1171-1177
[6]   Autoimmune Antibodies and Recurrence-Free Interval in Melanoma Patients Treated With Adjuvant Interferon [J].
Bouwhuis, Marna G. ;
Suciu, Stefan ;
Collette, Sandra ;
Aamdal, Steinar ;
Kruit, Wim H. ;
Bastholt, Lars ;
Stierner, Ulrika ;
Sales, Francois ;
Patel, Poulam ;
Punt, Cornelis J. A. ;
Hernberg, Micaela ;
Spatz, Alain ;
ten Hagen, Timo L. M. ;
Hansson, Johan ;
Eggermont, Alexander M. M. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (12) :869-877
[7]   Evidence for immune defects in breast and lung cancer patients [J].
Caras, I ;
Grigorescu, A ;
Stavaru, C ;
Radu, DL ;
Mogos, I ;
Szegli, G ;
Salageanu, A .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2004, 53 (12) :1146-1152
[8]   High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma [J].
Carreras, Joaquim ;
Lopez-Guillermo, Armando ;
Fox, Bridget C. ;
Colomo, Lluis ;
Martinez, Antonio ;
Roncador, Giovanna ;
Montserrat, Emili ;
Campo, Elias ;
Banham, Alison H. .
BLOOD, 2006, 108 (09) :2957-2964
[9]   The Janus face of dendritic cells in cancer [J].
Chaput, N. ;
Conforti, R. ;
Viaud, S. ;
Spatz, A. ;
Zitvogel, L. .
ONCOGENE, 2008, 27 (45) :5920-5931
[10]   The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research [J].
Cheever, Martin A. ;
Allison, James P. ;
Ferris, Andrea S. ;
Finn, Olivera J. ;
Hastings, Benjamin M. ;
Hecht, Toby T. ;
Mellman, Ira ;
Prindiville, Sheila A. ;
Viner, Jaye L. ;
Weiner, Louis M. ;
Matrisian, Lynn M. .
CLINICAL CANCER RESEARCH, 2009, 15 (17) :5323-5337